Catheter-Free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)

• Published in: Lasers in surgery and medicine 2008-10, Vol.40 (8), p.529-534
• Main Authors: Spaliviero, Massimiliano, Araki, Motoo, Page, Jay B., Wong, Carson
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; benign prostatic hyperplasia; catheter duration; Humans; KTP laser; Laser Therapy; LBO laser; lower urinary tract symptoms; Male; Middle Aged; outcomes; Prospective Studies; Prostatectomy - methods; Prostatic Hyperplasia - complications; Prostatic Hyperplasia - surgery; Prostatism - etiology; Prostatism - surgery; Urethra; Urinary Catheterization
• ISSN: 0196-8092; 1096-9101
• DOI: 10.1002/lsm.20678

Introduction and Objective We evaluate the safety and efficacy of catheter‐free LBO laser PVP for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Methods We prospectively evaluated our initial LBO laser PVP experience and the need for urethral catheterization. Results Seventy consecutive patients were identified. 49 (70%) were discharged without (C−) and 21 (30%) were discharged with (C+) a urethral catheter. There were no significant differences in pre‐operative parameters, including age (C−: 65±10 vs. C+: 69±9 years), AUASS (C−: 22±6 vs. C+: 21±6), Qmax (C−: 10±4 vs. C+: 8±3 ml/second), PVR (C−: 62±105 vs. C+: 57±82 ml) and prostate volume (C−: 65±35 vs. C+: 86±53 ml). There were no significant differences in laser time and energy usage. AUASS, Qmax and PVR values showed significant improvement within each group (P